United States courts of appeals

Former Federal Prosecutor Jaimie L. Nawaday Joins Seward & Kissel as Co-Head of Government Enforcement and Internal Investigations Group

Retrieved on: 
Tuesday, May 10, 2022

Seward & Kissel LLP announced today that Jaimie L. Nawaday , a former federal prosecutor in the Southern District of New York, has joined the firm in New York as co-head of the Government Enforcement and Internal Investigations Group and partner in the Litigation Department .

Key Points: 
  • Seward & Kissel LLP announced today that Jaimie L. Nawaday , a former federal prosecutor in the Southern District of New York, has joined the firm in New York as co-head of the Government Enforcement and Internal Investigations Group and partner in the Litigation Department .
  • View the full release here: https://www.businesswire.com/news/home/20220510005295/en/
    Jaimie L. Nawaday, partner in the Litigation Department and co-head of the Government Enforcement and Internal Investigations Group at Seward & Kissel LLP.
  • She is a remarkable lawyer with a breadth of experience working in the regulatory, enforcement, and investigations space, said Michael G. Considine , co-head of Seward & Kissels Litigation Department and Government Enforcement and Internal Investigations Group.
  • I am excited to help lead the extraordinarily talented Government Enforcement and Internal Investigations Group at Seward & Kissel, noted Nawaday.

Lawyers For Fair Reciprocal Admission Inc. Files Lawsuit Challenging United States District Court Local Rules That Deny General Admission to Out-Of-State Licensed Lawyers

Retrieved on: 
Wednesday, May 4, 2022

Lawyers For Fair Reciprocal Admission filed a lawsuit against the United States in the United States District Court in Trenton, N.J, docket number 3:22cv-02399 .

Key Points: 
  • Lawyers For Fair Reciprocal Admission filed a lawsuit against the United States in the United States District Court in Trenton, N.J, docket number 3:22cv-02399 .
  • The complaint seeks to invalidate local Rules in two-thirds of the 94 United States District Courts that deny general admission privileges to out-of-state licensed attorneys.
  • These challenged local Rules limit general bar admission to home-state licensed attorneys.
  • The ABA has recommended that District Courts and all States should adopt admission for licensed lawyers without taking another bar exam.

Belo Sun Reports On Two Court Rulings

Retrieved on: 
Tuesday, April 26, 2022

The Court has verbally advised the Company of the rulings, however it has yet to publish the written details of the ruling.

Key Points: 
  • The Court has verbally advised the Company of the rulings, however it has yet to publish the written details of the ruling.
  • Belo Sun reports that a three-judge panel of the Court has decided to postpone the ruling on the competent permitting authority for the environmental permitting of the Volta Grande Gold Project.
  • Belo Sun reports that a three-judge panel decision by the Court has ruled unanimously that it will not lift the Construction Licence suspension.
  • Forward-looking information includes, without limitation, statements regarding the cases before the Court of Appeals of the Federal Justice in Braslia; the rulings made by the Court and the impact of such rulings.

Eagle Pharmaceuticals Reaches Settlement Agreement with Hospira Related to BENDEKA® (bendamustine hydrochloride) until January 17, 2028

Retrieved on: 
Tuesday, April 19, 2022

WOODCLIFF LAKE, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (Eagle or the Company) today announced that it has reached a settlement agreement with Hospira, Inc (Hospira).

Key Points: 
  • WOODCLIFF LAKE, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (Eagle or the Company) today announced that it has reached a settlement agreement with Hospira, Inc (Hospira).
  • Eagle had asserted two Orange Book-listed patents against Hospira related to its new drug application (NDA) referencing BENDEKA.
  • The settlement agreement provides that Hospira has the right to market its product beginning January 17, 2028, or earlier based on certain circumstances.
  • The settlement agreement is confidential and subject to review by the U.S. Federal Trade Commission and the U.S. Department of Justice.

Ocwen Financial Comments on U.S. Court of Appeals Decision in CFPB Matter

Retrieved on: 
Friday, April 8, 2022

We are pleased that the appellate court adopted our position and acknowledged that the CFPB cannot unilaterally ignore the provisions of a prior settlement agreement.

Key Points: 
  • We are pleased that the appellate court adopted our position and acknowledged that the CFPB cannot unilaterally ignore the provisions of a prior settlement agreement.
  • Ocwen will continue to vigorously defend itself, as we have done throughout the course of this litigation.
  • The CFPB may only continue to advance claims for alleged conduct not covered by the terms of the 2014 consent judgment.
  • Ocwen Financial Corporation (NYSE: OCN) is a leading non-bank mortgage servicer and originator providing solutions through its primary brands, PHH Mortgage and Liberty Reverse Mortgage.

SEC Enforcement Staff Accessed Adjudicatory Documents in Midst of Administrative Proceedings

Retrieved on: 
Thursday, April 7, 2022

Washington, D.C., April 06, 2022 (GLOBE NEWSWIRE) -- The U.S. Securities and Exchange Commission (SEC) has disclosed that its enforcement staff accessed documents in at least two adjudicatory matters currently in litigation in federal court, including SEC v. Michelle Cochran.

Key Points: 
  • Washington, D.C., April 06, 2022 (GLOBE NEWSWIRE) -- The U.S. Securities and Exchange Commission (SEC) has disclosed that its enforcement staff accessed documents in at least two adjudicatory matters currently in litigation in federal court, including SEC v. Michelle Cochran.
  • SEC released a statement yesterday admitting that administrative support personnel from Enforcement, who were responsible for maintaining Enforcements case files, accessed [restricted] Adjudication memoranda via the Office of the Secretarys databases.
  • This self-described control deficiency is actually an outrageous breach of ethicsand possibly lawby SEC that illustrates why the Constitution forbids housing prosecutorial functions and adjudicatory functions in a single agency.
  • SEC filed in Cochran simultaneously with publishing the statement, so Ms. Cochran was not informed of SECs control deficiency when it was discovered.

NCLA Asks High Court to Grant Cert Now, Not Hold Case Questioning SEC’s Unconstitutional ALJs

Retrieved on: 
Tuesday, March 29, 2022

NCLA argues that the U.S. Supreme Court should reject the governments request to hold the Cochran case pending a decision in Axon Enterprise, Inc. v. FTC; instead, it should grant plenary review in Cochran and consolidate the case with Axon for argument next fall.

Key Points: 
  • NCLA argues that the U.S. Supreme Court should reject the governments request to hold the Cochran case pending a decision in Axon Enterprise, Inc. v. FTC; instead, it should grant plenary review in Cochran and consolidate the case with Axon for argument next fall.
  • The Fifth Circuit correctly held that Congress did not implicitly strip[] district courts of jurisdiction to hear structural constructional claims.
  • By filing a petition for certiorari in this case, the government conceded that this question merits Supreme Court review.
  • NCLA released the following statement:
    Michelle Cochran has already endured six years in the interminable waiting room of a federal district court.

TEA and American Benefits Council Jointly File Amicus Brief In Support of Arbitration Agreement

Retrieved on: 
Monday, March 14, 2022

WASHINGTON, March 14, 2022 /PRNewswire/ --The ESOP Association and American Benefits Council jointly filed an amicus brief in the U.S. Court of Appeals for the Second Circuit in support of the belief that ESOP plans need, and have, the ability to require individual arbitration to resolve individual participant disputes.

Key Points: 
  • WASHINGTON, March 14, 2022 /PRNewswire/ --The ESOP Association and American Benefits Council jointly filed an amicus brief in the U.S. Court of Appeals for the Second Circuit in support of the belief that ESOP plans need, and have, the ability to require individual arbitration to resolve individual participant disputes.
  • The brief argues several reasons a lower court ruling was incorrect and, if upheld, would effectively eliminate individualized arbitration of ERISA fiduciary-breach claims and may cause courts to question whether class actions are even required for such lawsuits.
  • Arbitration procedures are generally easier to navigate than court procedures, and both claimant and company can benefit by avoiding the high costs of attorneys.
  • Arbitration also has due process, oversight, and can be overruled by courts if they are deemed unfair.

Ariel Green and Jaime Cardenas-Navia Promoted to Partner at Reichman Jorgensen Lehman & Feldberg LLP

Retrieved on: 
Wednesday, March 2, 2022

REDWOOD SHORES, Calif., March 2, 2022 /PRNewswire/ -- Reichman Jorgensen Lehman & Feldberg LLP (RJLF), an elite majority women-owned trial boutique, announced that attorneys Ariel C. Green and Jaime F. Cardenas-Navia have been promoted to partner effective January 1, 2022.

Key Points: 
  • REDWOOD SHORES, Calif., March 2, 2022 /PRNewswire/ -- Reichman Jorgensen Lehman & Feldberg LLP (RJLF), an elite majority women-owned trial boutique, announced that attorneys Ariel C. Green and Jaime F. Cardenas-Navia have been promoted to partner effective January 1, 2022.
  • "Ariel and Jaime are extremely talented trial lawyers who have demonstrated an undeniable commitment to our clients and the firm," said Jennifer Estremera , RJLF's Deputy Managing Partner.
  • "The term 'rising star' is used so often these days, but Ariel and Jaime truly exemplify what it means to be a star trial lawyer," said Courtland Reichman , the firm's Managing Partner.
  • Reichman Jorgensen Lehman & Feldberg LLP (RJLF) is an elite national trial firm that handles high-stakes commercial litigation, intellectual property, and white collar disputes.

Genevant Sciences and Arbutus Biopharma File Patent Infringement Lawsuit Against Moderna

Retrieved on: 
Monday, February 28, 2022

and BASEL, Switzerland, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company, and Arbutus Biopharma Corporation (Nasdaq: ABUS) today filed a lawsuit in the U.S. District Court for the District of Delaware againstModerna, Inc. (Nasdaq: MRNA) and an affiliate seeking damages for infringement of U.S. Patent Nos.

Key Points: 
  • and BASEL, Switzerland, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company, and Arbutus Biopharma Corporation (Nasdaq: ABUS) today filed a lawsuit in the U.S. District Court for the District of Delaware againstModerna, Inc. (Nasdaq: MRNA) and an affiliate seeking damages for infringement of U.S. Patent Nos.
  • The patents relate to nucleic acid-lipid particles and lipid vesicles, as well as compositions and methods for their use.
  • Genevant and Arbutus do not seek an injunction or otherwise to impede the sale, manufacture or distribution of mRNA-1273.
  • Scientists at Arbutus and Genevant have spent years developing and refining lipid nanoparticle (LNP) delivery technology, which has been licensed for various applications to many different third parties.